Definitive Contract 75N95019C00029
- Not listed
- This is a $7,675,104.30 base award contract awarded by the National Institute on Drug Abuse (NIDA) to Virginia Commonwealth University (VCU) for preclinical medications discovery and abuse liability testing. The contract will run from February 22, 2022 to February 21, 2026, with a total potential value of up to $7,675,104.30 through February 21, 2027. The contract is for VCU to evaluate potential pharmacotherapies for drug use disorders in rodents and primates, and conduct abuse liability...
- This is a cost-reimbursement contract awarded by the National Institute on Drug Abuse (NIDA), part of the U.S. Department of Health and Human Services, to Virginia Commonwealth University (VCU) for $11,354,157.46. The contract is for preclinical medication discovery and abuse liability testing services in support of NIDA's mission. The contract has a period of performance from February 22, 2017 to February 21, 2018, with a potential completion date of February 16, 2025. This award is not...
- This is a five-year, $6,249,115.20 definitive contract awarded by the National Institute on Drug Abuse (NIDA) to The McLean Hospital Corporation, a non-profit psychiatric teaching hospital affiliated with Harvard Medical School. The contract is for the "Assessment of Potential Substance Abuse Treatment Medications in Nonhuman Primate Models." The original solicitation was a small business sources sought notice to obtain capability statements from small businesses for this work....
- This is a Cost Plus Fixed Fee contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Medavante, Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract, valued at $625,055.25, is for research and development in physical science. The contract has a period of performance through September 16, 2011. This contract is a definitive contract, indicating it is a stand-alone award rather than being associated with a larger...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $43,061.60 firm fixed price purchase order to Med Associates, Inc. for self-administration chambers to support research into brain mechanisms of compulsive drug use. Per the original solicitation, the Neuroimaging Research Branch requires additional self-administration training apparatuses for laboratory rats to self-administer compounds like methamphetamine while applying...
- This is a $876,368.00 Firm Fixed Price definitive contract awarded by the Food and Drug Administration (FDA) to Virginia Commonwealth University (VCU), a public research university. The contract is for the in vitro and in vivo assessment of buprenorphine extended release injections to evaluate generic product equivalence. The contract has been modified to extend the period of performance end date to September 29, 2026. VCU is a major recipient of federal contracts and grants, providing...
- This federal contract award, valued at $97,958.43, was made by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, to Med Associates, Inc., a for-profit, woman-owned manufacturer of scientific research equipment. The contract is for the delivery of modular operant conditioning and general behavior chambers for rats, which enable NIDA to conduct animal studies examining the behavioral and biological mechanisms underlying substance use...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $15,668.80 firm fixed price purchase order to Med Associates, Inc. for RAT BEHAVIOR BOX PARTS. The prime contractor, Med Associates, Inc. doing business as Med Associates Inc., will deliver the rat behavior box parts to support research being conducted at the place of performance in Baltimore, Maryland. The purchase order has a period of performance from July 26, 2023 through...
- This is a $12,264.50 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to Med Associates, Inc. The contract is for the delivery of custom rat behavior box parts to support an ongoing NIDA research project that started prior to January 20, 2025. This award was not set aside and is not associated with a larger contract vehicle. As a prime contractor, Med Associates has previously provided...
- The U.S. National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, awarded a $10,000.00 labor-hour purchase order contract to Christoph Kahl, a small business located in Thousand Oaks, California. The contract is for pharmaceutics formulation and chemistry manufacturing and controls (CMC) consulting services to support NIDA's drug discovery and development programs, including the NIH Blueprint Neurotherapeutics, Help End Addiction Longterm...
This is a $5,833,141.44 cost-reimbursable contract awarded by the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, to Virginia Commonwealth University (VCU) for medication discovery research using rat models of drug relapse. The contract has a period of performance from July 10, 2019 to July 9, 2024, with the initial award covering the first year. This contract was awarded under a competitive solicitation that was open to small businesses only, but no set-aside was used. The solicitation sought capabilities for in vivo rodent behavioral pharmacology research to evaluate the efficacy of novel compounds for treating drug dependence disorders, including cocaine, nicotine, methamphetamine, and opioids. VCU was selected based on its expertise and facilities for this type of specialized drug abuse research. The contract requires VCU to possess the necessary Drug Enforcement Administration registrations to handle controlled substances.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Medication Discovery Using Rat Models of Relapse | 75N950-19R-00004 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Award Notice 2/2 | 3/5/19, 2:29 PM | |
Medication Discovery Using Rat Models of Relapse | 75N950-19R-00004 | Department of Health and Human Services National Institutes of Health | Pre-Solicitation 1/2 | 11/6/18, 9:32 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00007 | Funding Only Action | ($79k) | 6/14/24 | |
| P00006 | Exercise an Option | $1.2m | 7/12/23 | |
| P00005 | Exercise an Option | $1.2m | 7/1/22 | |
| P00004 | Other Administrative Action | $0 | 11/24/21 | |
| P00003 | Other Administrative Action | $0 | 11/24/21 |